Please Wait
Applying Filters...
menu
    • menu
    DMF filings rise 4.5% in Q3 2025; China holds lead, India records 20% growth in submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Afatinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14,997Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/10/2025 Boehringer Ingelheim GmbH
    Germany
    		 Boehringer Ingelheim Korea Co., Ltd. Su2807-4-ND Afatinib dimaleate 2013-09-27 Boehringer Ingelheim Pharma GmbH & Co. K.G. Germany Binger Straße 173, D-55216 Ingelheim am Rhein, Germany
    31/10/2025 MSN Laboratories
    India
    		 Pharmapia Co., Ltd. Su674-3-ND(1) Afatinib dimaleate 2022-08-08 MSN Laboratories Private Limited India (Unit-II), Sy.No.50, Kardanur (village), Patti (Post), Patancheru (Mandal), Sangareddy District, Pincode-502 300. Telangana State, India.